MeSH D001919 - bradycardia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Epinephrine | Medihaler-epi |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Dopamine | Dopamine |  | 1989-01-24 |  |  |
| Lidocaine, Epinephrine | Lidocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| AbbVie | Atropine | Atropine |  | 1987-01-30 |  |  |
| Atropine, Meperidine | Atropine Demerol |  | 1982-11-26 |  |  | |
| Able Laboratories | Atropine, Diphenoxylate | Diphenoxylate Atropine |  | 2000-11-27 |  |  |
| Accord Healthcare | Atropine | Atropine |  | 2021-07-26 |  |  |
| Adamis Pharmaceuticals | Epinephrine | Symjepi | 2036-10-20 | 2017-06-15 |  |  |
| Alcon Research | Atropine | Isopto Atropine |  | 2016-12-01 |  |  |
| Allergan | Atropine, Diphenoxylate | Diphenoxylate Atropine |  | 1982-01-01 |  |  |
| Lidocaine, Epinephrine | Lidocaine W/ Epinephrine |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
33%1/3
Phase 3
88%7/8
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use